bladder cancer
The Bladder Cancer Advocacy Network organized the UC-GENOME study and is now offering more grant funding to support clinical trials in bladder cancer.
Diagnostics Developer Early is Good Raises $4M in Seed Funding
The company will use the funds to complete clinical trials for its first product, BCDx, a laboratory-developed test for early bladder cancer detection.
Immune Checkpoint Blockade Response Linked to Recurrent Mutations in Genes, Pathways
Exome sequences for hundreds of cancer patients led researchers to four recurrently mutated genes and several pathways with ties to immunotherapy response.
Nucleix Expands EU Label Indication for Bladder Cancer Urine Test
The test measures DNA methylation patterns in urine that are associated with urothelial cancer and was first launched for monitoring tumor recurrence.
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.